• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状腺相关性眼病的发病机制:针对肌浆网钙结合蛋白和ⅩⅢ型胶原蛋白的自身免疫是否起作用?

Pathogenesis of thyroid-associated ophthalmopathy: does autoimmunity against calsequestrin and collagen XIII play a role?

作者信息

Lahooti Hooshang, Parmar Kishan R, Wall Jack R

机构信息

The Department of Medicine, University of Sydney, Nepean Clinical School, Penrith, NSW, Australia.

出版信息

Clin Ophthalmol. 2010 May 14;4:417-25. doi: 10.2147/opth.s6534.

DOI:10.2147/opth.s6534
PMID:20505833
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2874268/
Abstract

Thyroid-associated ophthalmopathy (TAO), or thyroid eye disease, is a complex inflammatory disorder of the eye that, as its name implies, is associated with thyroid disease. TAO can be divided into three subtypes: ocular myopathy, congestive myopathy and mixed congestive and myopathic ophthalmopathy. Although the precise pathophysiology of TAO remains unclear it is likely to reflect an autoimmune reaction involving sensitized T-cells and autoantibodies directed against a thyroid and orbital tissue shared antigen. One well studied candidate in this immune reaction is the thyroid-stimulating hormone receptor (TSH-r), expressed in the orbital fibroblast and pre adipocyte. In our studies of TAO, we have investigated the nature and significance of antibodies targeting other eye muscle and orbital connective tissue (OCT) antigens. Our findings suggest that autoimmunity against the eye muscle antigen calsequestrin and the OCT antigen collagen XIII plays a role in the pathogenesis of TAO. We propose that ocular myopathy and chronic eyelid retraction are due to autoimmunity against skeletal muscle calsequestrin in the extraocular and eyelid muscles, respectively. This may be initiated in the thyroid where calsequestrin expression is upregulated, possibly due to a stimulatory effect of TSH-r antibodies. We also propose that congestive ophthalmopathy results from a reaction against the TSH-r or collagen XIII in orbital fibroblast cell membranes. Further insight into the role of eye muscle and OCT antigens in the pathogenesis of TAO may allow for the development of new therapies to treat the eye disorder and reduce patient morbidity.

摘要

甲状腺相关性眼病(TAO),又称甲状腺眼病,是一种复杂的眼部炎症性疾病,顾名思义,它与甲状腺疾病相关。TAO可分为三种亚型:眼型肌病、充血性肌病以及充血性与肌病混合型眼病。尽管TAO的确切病理生理学机制尚不清楚,但很可能反映了一种自身免疫反应,涉及致敏T细胞和针对甲状腺及眼眶组织共同抗原的自身抗体。这种免疫反应中一个经过充分研究的候选对象是促甲状腺激素受体(TSH-r),它在眼眶成纤维细胞和前脂肪细胞中表达。在我们对TAO的研究中,我们调查了靶向其他眼肌和眼眶结缔组织(OCT)抗原的抗体的性质和意义。我们的研究结果表明,针对眼肌抗原肌集钙蛋白和OCT抗原胶原蛋白XIII的自身免疫在TAO的发病机制中起作用。我们提出,眼型肌病和慢性眼睑退缩分别是由于眼外肌和眼睑肌中针对骨骼肌肌集钙蛋白的自身免疫所致。这可能始于甲状腺,在那里肌集钙蛋白表达上调,可能是由于TSH-r抗体的刺激作用。我们还提出,充血性眼病是由针对眼眶成纤维细胞膜中的TSH-r或胶原蛋白XIII的反应引起的。进一步深入了解眼肌和OCT抗原在TAO发病机制中的作用,可能有助于开发新的疗法来治疗这种眼部疾病并降低患者的发病率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a5e/2874268/fb4aa23ccca2/opth-4-417f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a5e/2874268/5d6b2d826a49/opth-4-417f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a5e/2874268/fb4aa23ccca2/opth-4-417f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a5e/2874268/5d6b2d826a49/opth-4-417f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a5e/2874268/fb4aa23ccca2/opth-4-417f2.jpg

相似文献

1
Pathogenesis of thyroid-associated ophthalmopathy: does autoimmunity against calsequestrin and collagen XIII play a role?甲状腺相关性眼病的发病机制:针对肌浆网钙结合蛋白和ⅩⅢ型胶原蛋白的自身免疫是否起作用?
Clin Ophthalmol. 2010 May 14;4:417-25. doi: 10.2147/opth.s6534.
2
[Pathogenesis of thyroid eye disease - does autoimmunity against the TSH receptor explain all cases?].[甲状腺眼病的发病机制——针对促甲状腺激素受体的自身免疫能解释所有病例吗?]
Endokrynol Pol. 2011;62 Suppl 1:1-7.
3
Pathogenesis of thyroid eye disease--does autoimmunity against the TSH receptor explain all cases?甲状腺眼病的发病机制——抗 TSH 受体自身免疫能否解释所有病例?
Endokrynol Pol. 2010 Mar-Apr;61(2):222-7.
4
Study of serum antibodies against three eye muscle antigens and the connective tissue antigen collagen XIII in patients with Graves' disease with and without ophthalmopathy: correlation with clinical features.伴有和不伴有眼病的格雷夫斯病患者血清中针对三种眼肌抗原和结缔组织抗原ⅩⅢ型胶原的抗体研究:与临床特征的相关性
Thyroid. 2006 Oct;16(10):967-74. doi: 10.1089/thy.2006.16.967.
5
Long-term follow-up of seven patients with ophthalmopathy not associated with thyroid autoimmunity: heterogeneity of autoimmune ophthalmopathy.7例非甲状腺自身免疫性眼病患者的长期随访:自身免疫性眼病的异质性
Clin Ophthalmol. 2012;6:1063-71. doi: 10.2147/OPTH.S30704. Epub 2012 Jul 12.
6
Thyroid-associated ophthalmopathy: clinical features, pathogenesis, and management.甲状腺相关性眼病:临床特征、发病机制及治疗
Crit Rev Clin Lab Sci. 2000 Dec;37(6):523-49. doi: 10.1080/10408360091174303.
7
Eye signs and serum eye muscle and collagen XIII antibodies in patients with transient and progressive thyroiditis.短暂性和进行性甲状腺炎患者的眼部体征及血清眼肌和胶原蛋白 XIII 抗体
Thyroid. 2007 Nov;17(11):1123-9. doi: 10.1089/thy.2007.0054.
8
Antibodies against calsequestrin and type XIII collagen are good markers for chronic upper eyelid retraction.抗肌集钙蛋白和 XIII 型胶原蛋白的抗体是慢性上睑退缩的良好标志物。
Ocul Immunol Inflamm. 2007 Mar-Apr;15(2):81-8. doi: 10.1080/09273940701299362.
9
Antibody-dependent cell-mediated cytotoxicity against orbital target cells in thyroid-associated ophthalmopathy and related disorders; close relationship between serum cytotoxic antibodies and parameters of eye muscle dysfunction.甲状腺相关性眼病及相关疾病中针对眼眶靶细胞的抗体依赖性细胞介导的细胞毒性;血清细胞毒性抗体与眼肌功能障碍参数之间的密切关系。
J Endocrinol Invest. 1996 Jun;19(6):334-41. doi: 10.1007/BF03344966.
10
Tc-octreotide scintigraphy and serum eye muscle antibodies in evaluation of active thyroid-associated ophthalmopathy.锝标记奥曲肽闪烁扫描术及血清眼肌抗体在活动性甲状腺相关性眼病评估中的应用
Eye (Lond). 2017 May;31(5):668-676. doi: 10.1038/eye.2017.42. Epub 2017 Apr 7.

引用本文的文献

1
Expression of Collagen XIII in Tissues of the Thyroid and Orbit With Relevance to Thyroid-Associated Ophthalmopathy.胶原 XIII 在甲状腺和眼眶组织中的表达及其与甲状腺相关眼病的关系。
Invest Ophthalmol Vis Sci. 2024 Apr 1;65(4):6. doi: 10.1167/iovs.65.4.6.
2
Non-coding RNA-mediated epigenetic alterations in Grave's ophthalmopathy: A scoping systematic review.非编码RNA介导的格雷夫斯眼病表观遗传改变:一项范围界定性系统评价
Noncoding RNA Res. 2023 May 16;8(3):426-450. doi: 10.1016/j.ncrna.2023.04.001. eCollection 2023 Sep.
3
Changes of Volume Parameters in the Treatment of Graves Ophthalmopathy by Endoscopic Transethmoidal Decompression of the Orbital Inner Wall Combined with Fat Decompression.

本文引用的文献

1
Eye and eyelid abnormalities are common in patients with Hashimoto's thyroiditis.甲状腺功能减退症患者常伴有眼部和眼睑异常。
Thyroid. 2010 Mar;20(3):287-90. doi: 10.1089/thy.2009.0199.
2
The cardiac calsequestrin gene (CASQ2) is up-regulated in the thyroid in patients with Graves' ophthalmopathy--support for a role of autoimmunity against calsequestrin as the triggering event.甲状腺中的心脏钙结合蛋白基因(CASQ2)在格雷夫斯眼病患者中上调——支持自身免疫针对钙结合蛋白作为触发事件的作用。
Clin Endocrinol (Oxf). 2010 Oct;73(4):522-8. doi: 10.1111/j.1365-2265.2009.03753.x.
3
Avicenna, the first to describe thyroid-related orbitopathy.
内镜经鼻筛窦眶内壁减压联合脂肪减压治疗格雷夫斯眼病容积参数的变化。
Scanning. 2022 Aug 24;2022:8149247. doi: 10.1155/2022/8149247. eCollection 2022.
4
Eye symptoms in patients with benign thyroid diseases.良性甲状腺疾病患者的眼部症状。
Sci Rep. 2021 Sep 21;11(1):18706. doi: 10.1038/s41598-021-98232-0.
5
Prognostic factors of restrictive myopathy in thyroid eye disease.甲状腺眼病限制性肌病的预后因素。
Sci Rep. 2021 Jul 2;11(1):13781. doi: 10.1038/s41598-021-93275-9.
6
A case report of thyroid-associated Orbitopathy with elevated TPO antibodies.甲状腺相关性眼病伴 TPO 抗体升高 1 例报告。
BMC Endocr Disord. 2020 Nov 27;20(1):176. doi: 10.1186/s12902-020-00658-6.
7
MicroRNAs and Autoimmune-Mediated Eye Diseases.微小RNA与自身免疫介导的眼部疾病
Front Cell Dev Biol. 2020 Aug 20;8:818. doi: 10.3389/fcell.2020.00818. eCollection 2020.
8
Hashimoto's thyroiditis associated with acute painful unilateral ophthalmoplegia.桥本甲状腺炎伴急性疼痛性单侧眼肌麻痹。
Neurol Sci. 2020 Jan;41(1):213-215. doi: 10.1007/s10072-019-04032-w. Epub 2019 Aug 5.
9
Severe unilateral orbitopathy in a patient with Hashimoto's thyroiditis - a case report.桥本甲状腺炎患者的严重单侧眼眶病——病例报告
BMC Ophthalmol. 2019 Jan 8;19(1):9. doi: 10.1186/s12886-018-1018-5.
10
Biomarker identification of thyroid associated ophthalmopathy using microarray data.利用微阵列数据鉴定甲状腺相关性眼病的生物标志物
Int J Ophthalmol. 2018 Sep 18;11(9):1482-1488. doi: 10.18240/ijo.2018.09.09. eCollection 2018.
阿维森纳,第一个描述甲状腺相关眼病的人。
Thyroid. 2009 Jan;19(1):7-8. doi: 10.1089/thy.2008.0299.
4
Peripheral blood T lymphocyte sensitisation against calsequestrin and flavoprotein in patients with Graves' ophthalmopathy.格雷夫斯眼病患者外周血T淋巴细胞对肌集钙蛋白和黄素蛋白的致敏作用
Autoimmunity. 2008 Aug;41(5):372-6. doi: 10.1080/08916930801931142.
5
Eye signs and serum eye muscle and collagen XIII antibodies in patients with transient and progressive thyroiditis.短暂性和进行性甲状腺炎患者的眼部体征及血清眼肌和胶原蛋白 XIII 抗体
Thyroid. 2007 Nov;17(11):1123-9. doi: 10.1089/thy.2007.0054.
6
Thyroid-related orbitopathy: concepts and management.甲状腺相关眼病:概念与管理
Facial Plast Surg. 2007 Aug;23(3):168-73. doi: 10.1055/s-2007-984556.
7
Psychological implications of Graves' orbitopathy.格雷夫斯眼眶病的心理影响。
Eur J Endocrinol. 2007 Aug;157(2):127-31. doi: 10.1530/EJE-07-0205.
8
Antibodies against calsequestrin and type XIII collagen are good markers for chronic upper eyelid retraction.抗肌集钙蛋白和 XIII 型胶原蛋白的抗体是慢性上睑退缩的良好标志物。
Ocul Immunol Inflamm. 2007 Mar-Apr;15(2):81-8. doi: 10.1080/09273940701299362.
9
Susceptibility genes in Graves' ophthalmopathy: searching for a needle in a haystack?格雷夫斯眼病的易感基因:大海捞针?
Clin Endocrinol (Oxf). 2007 Jul;67(1):3-19. doi: 10.1111/j.1365-2265.2007.02854.x. Epub 2007 May 23.
10
Study of serum antibodies against three eye muscle antigens and the connective tissue antigen collagen XIII in patients with Graves' disease with and without ophthalmopathy: correlation with clinical features.伴有和不伴有眼病的格雷夫斯病患者血清中针对三种眼肌抗原和结缔组织抗原ⅩⅢ型胶原的抗体研究:与临床特征的相关性
Thyroid. 2006 Oct;16(10):967-74. doi: 10.1089/thy.2006.16.967.